| Literature DB >> 34123900 |
Gandham Ravi1, Gaurav Chikara1, Arkapal Bandyopadhyay1, Shailendra Handu1.
Abstract
BACKGROUND AND AIM: Global scenario of antimicrobial (AM) utilization depicts 20-50% inappropriateness. Majority of the hospital admissions are due to unwanted effects because of non-judicial usage of these drugs. The present study focuses on utilization pattern of antimicrobials (AMs) in a tertiary care hospital in northern India.Entities:
Keywords: ADR profiling; W.H.O indicators; antimicrobial/antibiotic; consumption
Year: 2021 PMID: 34123900 PMCID: PMC8144753 DOI: 10.4103/jfmpc.jfmpc_1230_20
Source DB: PubMed Journal: J Family Med Prim Care ISSN: 2249-4863
Baseline characteristics of the study population
| Distribution of cases among the selected departments ( | Mean age (range) | Sex distribution | Co-morbidities# | Reason for AM prescription- Patient distribution | System involved in empirical therapy* |
|---|---|---|---|---|---|
| Medicine-104; | 38.59 years | Males-321 | Malignancy- 4.20% | Prophylactic- 20.40% | R/S- 42% |
| Surgery-105; | (1-70 years) | Females-379 | Coronary artery disease-0.70% | Empirical- 44.80% | GIT- 36% |
| OBG-100; | CKD- 1.10% | Definitive- 34.70% | Renal- 12% | ||
| Pediatrics-97; | CLD- 1.10% | CNS- 10% | |||
| Orthopedics-97; | COPD- 4.40% | ||||
| ENT-94; | DM - 3.70% | ||||
| Pulmonary medicine. -103 | HTN- 1.40% |
#CKD: Chronic kidney disease; CLD: Chronic liver disease; COPD: Chronic obstructive pulmonary disease; DM: Diabetes mellitus; HTN: Hypertension. *R/S: Respiratory system; GIT: Gastro intestinal tract; CNS: Central nervous system
Results of Hospital Indicators
| Parameter | Result |
|---|---|
| Presence of drugs and therapeutics committee (DTC) | Yes |
| Availability of STGs to treat infections | No |
| Availability of Essential medicines list | Yes |
| Number of antibiotics on the EML | 82 generics |
| Percentage of medications denoted by generic name (INN) | 100% |
| Availability of a set of key antimicrobials in the wards at the time of visit | 100% |
| Average number of days that a set of key antibiotics found unavailable | Zero days/month |
| Amount spent on antibiotics as a percentage of the total hospital medicine expenditure | 29.87% |
Prescribing indicators results (Indicators 6-10, 13, 14)
| Indicator | Department | ||||||
|---|---|---|---|---|---|---|---|
| General medicine | General surgery | Pediatrics | OBG | ENT | Pulmonary medicine | Orthopedics | |
| % of hospitalizations with one or more AMs | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Average number of AMs per hospitalization in which AMs are prescribed (SD) | 1.93 (0.87) | 1.91 (0.96) | 1.75 (1.09) | 2.29 (0.84) | 1.26 (0.60) | 2.05 (1.08) | 1.82 (0.58) |
| % of AMs prescribed from FL/EML | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| Average cost of AMs prescribed per hospitalization in which AMs were prescribed | 299.11 | 270.35 | 129.27 | 102.08 | 145.74 | 402.41 | 198.75 |
| Average duration of prescribed AMs treatment days (SD) | 5.41 (2.83) | 5.05 (3.49) | 6.16 (3.52) | 3.51 (1.77) | 3.30 (1.71) | 7.79 (4.57) | 3.95 (2.02) |
| % of Pneumonia patients who received AMs | 100 | 0 | 100 | 0 | 0 | 100 | 0 |
| % of patients who received treatment for pneumonia as per STGs* | 100 | - | 100 | - | - | 71.4 | - |
| % of AMs prescribed by INN | 74.1 | 57.1 | 73 | 54.4 | 8.8 | 49.3 | 95 |
*National Treatment Guidelines for Antimicrobial Use in Infectious Diseases. Version 1.0 (2016)
Results of Surgical antimicrobial prophylaxis indicators (Indicators 11, 12)
| Parameter | Results |
|---|---|
| Number of patients underwent lower segment cesarean section (LSCS) | 57 |
| Number of patients receiving prophylactic antibiotics | 57 |
| Total number of prophylactic antibiotic doses prescribed for LSCS procedures | 971 |
| Average number of prophylactic doses prescribed for LSCS procedures | 17.03 |
| Percentage of patients receiving prophylactic AMs for LSCS according to the clinical guidelines* | None |
*All Wales Medicines Strategy Group, All Wales Antimicrobial Guidance Group. Guidance on Antimicrobial Prophylaxis Related to Caesarean Section. September 2015
Results of Patient-care and supplemental indicators (Indicators 15-17)
| Parameter | Departments | ||||||
|---|---|---|---|---|---|---|---|
| General medicine | General surgery | Pediatrics | OBG | E.N. T | Pulmonary medicine | Orthopedics | |
| Number of AM doses prescribed Sum (mean±SD) | 2185 (10.97±6.68) | 2459 (11.33±8.92) | 2244 (13.12±9.98) | 1769 (7.41±4.66) | 1189 (9±5.66) | 3747 (17.42±13.05) | 1295 (7.19±4.13) |
| Percent of doses of prescribed AM actually administered | 97.71 | 99.3 | 98.30 | 99.37 | 98.99 | 98.74 | 98.37 |
| Average duration of hospital stay of patients who received AM (SD) | 9.14 (4.78) | 8.96 (5.46) | 8.39 (4.9) | 7.68 (4.85) | 3.30 (1.71) | 11.67 (5.58) | 10.37 (7.91) |
| Number of AM drug sensitivity tests reported per hospital admission with curative AM prescribed | 53 | 28 | 56 | 35 | 3 | 59 | 8 |
OBG: Obstetrics and gynecology; ENT: Ear Nose Throat (Oto-rhino -laryngology); AM: Antimicrobial; SD: Standard Deviation
Figure 1Antimicrobial consumption in individual departments (expressed in DDD/100 bed days)
Figure 2Overall antimicrobial consumption (expressed in DDD/100 bed days)
ADRs associated with AMs
| Antibiotic | ADR | Percentage | WHO-UMC* Classification |
|---|---|---|---|
| Amoxicillin + clavulanic acid | Gastritis | 36.36 | Possible |
| Vancomycin | Skin Rash | 5.45 | Certain |
| Piperacillin + Tazobactam | Gastritis | 20 | Possible |
| Ceftriaxone | Gastritis | 9.09 | Possible |
| Doxycycline | Gastritis | 3.63 | Possible |
| Levofloxacin | Gastritis | 5.45 | Possible |
| Azithromycin | Gastritis | 3.63 | Possible |
| Ciprofloxacin | Gastritis | 9.09 | Possible |
| Cefoperazone + Sulbactam | Gastritis | 5.45 | Possible |
| Ampicillin + sulbactam | Gastritis | 1.81 | Possible |
*W.H. O-UMC: World health organization- Uppsala Monitoring Centre